The global pandemic of SARS-CoV-2, the causative viral pathogen of COVID-19, has driven
the biomedical community to action—to uncover and develop antiviral interventions. One …

In order to inhibit pathogenic complications and to enhance animal and poultry growth,
antibiotics have been extensively used for many years. Antibiotics applications not only …

SARS-CoV-2 is responsible for the current COVID-19 pandemic. On the basis of our
analysis of hepatitis C virus and coronavirus replication, and the molecular structures and …

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was
recognised by the WHO as a pandemic in 2020. Host preparation to combat the virus is an …

Background: It is unclear how characteristics, risk factors, and incidence of coronavirus
disease 2019 (COVID-19) in people living with HIV (PLWH) differ from the general …

As the COVID-19 is still growing throughout the globe, a thorough investigation into the
specific immunopathology of SARS-CoV-2, its interaction with the host immune system and …

Objectives Sofosbuvir and daclatasvir are direct-acting antivirals highly effective against
hepatitis C virus. There is some in silico and in vitro evidence that suggests these agents …

Abstract SARS-CoV-2, a member of the coronavirus family, is responsible for the current
COVID-19 worldwide pandemic. We previously demonstrated that five nucleotide analogues …

The emergence of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …

SARS-CoV-2 is responsible for COVID-19, resulting in the largest pandemic in over a
hundred years. After examining the molecular structures and activities of hepatitis C viral …